PDS Biotechnology Corp — Director's Dealing 2022

Dec 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PDS Biotechnology Corp (PDSB)
CIK: 0001472091
Period of Report: 2022-12-02

Reporting Person: BEDU-ADDO FRANK (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-02	Common Stock	M	219535	$6.57	Acquired	866050	Direct
2022-12-02	Common Stock	F	175184	$9.78	Disposed	690866	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-02	Stock Option (Right to Buy)	$6.57	M	219535	Disposed	2022-12-03	Common Stock (219535)	Direct

Footnotes

F1: This stock option was fully vested in accordance with its terms.

F2: On December 2, 2022, Dr. Bedu-Addo made a net exercise of 219,535 stock options, resulting in his acquisition of 44,351 common shares of the Issuer.